DK1435999T3 - Kombination af to bioaktive regioner af pro-opiomelanocortin-hormon - Google Patents

Kombination af to bioaktive regioner af pro-opiomelanocortin-hormon

Info

Publication number
DK1435999T3
DK1435999T3 DK01988010.3T DK01988010T DK1435999T3 DK 1435999 T3 DK1435999 T3 DK 1435999T3 DK 01988010 T DK01988010 T DK 01988010T DK 1435999 T3 DK1435999 T3 DK 1435999T3
Authority
DK
Denmark
Prior art keywords
opiomelanocortin
hormon
pro
combination
bioactive regions
Prior art date
Application number
DK01988010.3T
Other languages
English (en)
Inventor
Zlatko Ademovic
Nikola Stambuk
Pasko Konjevoda
Darko Mikus
Original Assignee
Zlatko Ademovic
Darko Mikus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zlatko Ademovic, Darko Mikus filed Critical Zlatko Ademovic
Application granted granted Critical
Publication of DK1435999T3 publication Critical patent/DK1435999T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/34—Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK01988010.3T 2001-10-18 2001-11-29 Kombination af to bioaktive regioner af pro-opiomelanocortin-hormon DK1435999T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BA010898 2001-10-18
PCT/BA2001/000005 WO2003033017A1 (en) 2001-10-18 2001-11-29 Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone

Publications (1)

Publication Number Publication Date
DK1435999T3 true DK1435999T3 (da) 2012-10-22

Family

ID=3839672

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01988010.3T DK1435999T3 (da) 2001-10-18 2001-11-29 Kombination af to bioaktive regioner af pro-opiomelanocortin-hormon

Country Status (15)

Country Link
US (1) US7544653B2 (da)
EP (1) EP1435999B1 (da)
JP (1) JP2005508356A (da)
CN (1) CN1321687C (da)
AU (1) AU2002240733B2 (da)
BR (1) BR0117155A (da)
CA (1) CA2462713C (da)
CY (1) CY1114016T1 (da)
DK (1) DK1435999T3 (da)
ES (1) ES2391551T3 (da)
MX (1) MXPA04003504A (da)
NO (1) NO20042001L (da)
PT (1) PT1435999E (da)
RU (1) RU2297238C2 (da)
WO (1) WO2003033017A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2857588B1 (fr) * 2003-07-17 2007-11-30 Oreal Utilisation de beta-endorphine, d'agents exercant une activite beta-endorphine-like en cosmetique et dermatologie
AU2011265315B2 (en) * 2004-05-12 2014-08-28 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods related to the treatment of neurodegenerative and inflammatory conditions
WO2010054446A1 (en) 2008-11-11 2010-05-20 Ademovic Zlatko Combination of two or more peptides in a single stable lyophilized pharmaceutical compound
WO2015033175A1 (en) 2013-09-06 2015-03-12 Zlatko Ademovic Combination of pro-opiomelanocortin endogenous peptides in autoimmune disease treatment
US10644009B2 (en) 2017-12-21 2020-05-05 Renesas Electronics Corporation Semiconductor memory device
CN109824772B (zh) * 2019-02-28 2022-07-29 海南大学 一组提高血清糖皮质激素水平的基因重组人促皮质素前体及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU758160B2 (en) * 1997-08-22 2003-03-20 Kaken Pharmaceutical Co., Ltd. Novel amide derivatives
WO2000004873A1 (en) * 1998-07-22 2000-02-03 Smith & Nephew Plc Dermatological compositions for the treatment of scars
WO2000069900A2 (en) * 1999-05-17 2000-11-23 Conjuchem, Inc. Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components

Also Published As

Publication number Publication date
WO2003033017A1 (en) 2003-04-24
BR0117155A (pt) 2004-10-26
RU2004114992A (ru) 2005-04-20
CA2462713A1 (en) 2003-04-24
US7544653B2 (en) 2009-06-09
AU2002240733B2 (en) 2009-04-09
CY1114016T1 (el) 2016-07-27
JP2005508356A (ja) 2005-03-31
ES2391551T3 (es) 2012-11-27
CA2462713C (en) 2014-03-18
PT1435999E (pt) 2012-10-24
CN1558772A (zh) 2004-12-29
RU2297238C2 (ru) 2007-04-20
NO20042001L (no) 2004-05-14
US20050014696A1 (en) 2005-01-20
EP1435999A1 (en) 2004-07-14
MXPA04003504A (es) 2005-06-20
EP1435999B1 (en) 2012-07-18
CN1321687C (zh) 2007-06-20

Similar Documents

Publication Publication Date Title
DK1438306T3 (da) Derivater af UK-2A
DK1417180T3 (da) Fremstilling af aminopyrimidinforbindelser
DE60129705D1 (de) Monoalkylglycerinäther stabile zusammensetzungen
DK1390377T3 (da) Ny krystalform af azithromycin
DK2363414T3 (da) Stedstyret modifikation af FVIII
DE60210429D1 (de) Stabile elektrolumineszenzvorrichtungen
DK1763673T3 (da) Anvendelser af gelformuleringer
DK1448044T3 (da) Plantepotte af plastmateriale
DK2377931T3 (da) Varianter af glycosidhydrolase
DK1393047T3 (da) Selektiv skelnen af planter
BRPI0313075A2 (pt) composições de vidro
PT1250321E (pt) Composicao de gliburida
DK1458447T3 (da) Kombination af cytokrom-p450-beroende proteasinhibitorer
ITTO20020627A1 (it) Interruttore multipolare di tipo contattore-disgiuntore
DE60215601D1 (de) Stabile Zusammensetzung
DK1354027T3 (da) Stabilisering af drikkevarer
DK1578774T3 (da) Oprensning af immunoglobuliner
DK1377544T3 (da) Oprensning af 2-nitro-4-methylsulfonylbenzoesyre
NO20021134L (no) Selv-kompenserende klokke tilpasset brönn-anvendelser
DK1435999T3 (da) Kombination af to bioaktive regioner af pro-opiomelanocortin-hormon
DK1337228T3 (da) Sammensætninger til fjernelse af human cerumen
PT1429926E (pt) Circuito de interligacao
DK1313491T3 (da) Bioaktiv fraktion af eurycoma longifolia
DK1451433T3 (da) Glassammensætning
DK1400522T3 (da) Forbindelser til behandling af impotens